<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2805245370
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Sesmo
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ESOMEPRAZOLE MAGNESIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule, hard
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        52.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BC05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Sesmo contains a medicine called esomeprazole. This belongs to a group of medicines<br />called &lsquo;proton pump inhibitors&rsquo;. They work by reducing the amount of acid that your<br />stomach produces.<br /><strong>Sesmo is used to treat the following conditions:</strong><br /><strong>Adults</strong><br />&bull; &lsquo;Gastro-Oesophageal Reflux Disease&rsquo; )GORD(. This is where acid from the stomach<br />escapes into the oesophagus )the tube which connects your throat to your stomach(<br />causing pain, inflammation and heartburn.<br />&bull; Ulcers in the stomach or upper part of the gut )intestine( that are infected with<br />bacteria called &lsquo;Helicobacter pylori&rsquo;. If you have this condition, your doctor may also<br />prescribe antibiotics to treat the infection and allow the ulcer to heal.<br />&bull; Stomach ulcers caused by medicines called NSAIDs )Non-Steroidal AntiInflammatory Drugs(. Sesmo can also be used to stop stomach ulcers from forming<br />if you are taking NSAIDs.<br />&bull; Too much acid in the stomach caused by a growth in the pancreas )Zollinger-Ellison<br />syndrome(.<br />&bull; Prolonged treatment after prevention of rebleeding of ulcers with intravenous<br />esomeprazole.<br /><strong>Adolescents aged 12 years and above</strong><br />&bull; &lsquo;Gastro-Oesophageal Reflux Disease&rsquo; )GORD(. This is where acid from the stomach<br />escapes into the esophagus )the tube which connects your throat to your stomach(<br />causing pain, inflammation and heartburn.<br />&bull; Ulcers in the stomach or upper part of the gut )intestine( that are infected with<br />bacteria called &lsquo;Helicobacter pylori&rsquo;. If you have this condition, your doctor may also<br />prescribe antibiotics to treat the infection and allow the ulcer to heal.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Sesmo:</strong><br />&bull; If you are allergic to esomeprazole or any of the other ingredients of this medicine<br />)listed in Section 6(.<br />&bull; If you are allergic to other proton pump inhibitor medicines )e.g. pantoprazole,<br />lansoprazole, rabeprazole, omeprazole(.<br />&bull; If you are taking a medicine containing nelfinavir )used to treat HIV infection(.<br /><strong>Do not take Sesmo if any of the above apply to you. If you are not sure, talk<br />to your doctor or pharmacist before taking Sesmo.</strong><br /><strong>Warnings and precautions:</strong><br />Talk to your doctor or pharmacist before taking Sesmo:<br />&bull; If you have severe liver problems.<br />&bull; If you have severe kidney problems.<br />&bull; If you have ever had a skin reaction after treatment with a medicine similar to<br />Sesmo that reduces stomach acid.<br />&bull; If you are due to have a specific blood test )Chromogranin A(.<br />&bull; If you have vitamin B12 deficiency<br /><strong>Sesmo may hide the symptoms of other diseases. Therefore, if any of the<br />following happen to you before you start taking Sesmo or while you are<br />taking it, talk to your doctor straight away:</strong><br />&bull; You lose a lot of weight for no reason and have problems swallowing.<br />&bull; You get stomach pain or indigestion.<br />&bull; You begin to vomit food or blood.<br />&bull; You pass black stools )blood-stained faeces(.<br />* If you have been prescribed Sesmo &ldquo;on demand&rdquo; you should contact your doctor if<br />your symptoms continue or change in character.<br />* Taking a proton pump inhibitor like Sesmo, especially over a period of more than<br />one year, may slightly increase your risk of fracture in the hip, wrist or spine. Tell<br />your doctor if you have osteoporosis or if you are taking corticosteroids )which can<br />increase the risk of osteoporosis(.<br />* If you get a rash on your skin, especially in areas exposed to the sun tell your doctor<br />as soon as you can, as you may need to stop your treatment with Sesmo. Remember<br />to also mention any other ill-effects like pain in your joints.<br /><strong>Other medicines and Sesmo</strong><br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any<br />other medicines. This includes medicines that you buy without a prescription. This<br />is because Sesmo can affect the way some medicines work and some medicines can<br />have an effect on Sesmo.<br />Do not take Sesmo Capsules if you are taking a medicine containing nelfinavir )used<br />to treat HIV infection(.<br />Tell your doctor or pharmacist if you are taking any of the following medicines:<br />&bull; Atazanavir )used to treat HIV infection(.<br />&bull; Clopidogrel )used to prevent blood clots(.<br />&bull; Ketoconazole, itraconazole or voriconazole )used to treat infections caused by a<br />fungus(.<br />&bull; Erlotinib )used to treat cancer(.<br />&bull; Citalopram, imipramine or clomipramine )used to treat depression(.<br />&bull; Diazepam )used to treat anxiety, relax muscles or in epilepsy(.<br />&bull; Phenytoin )used in epilepsy(. If you are taking phenytoin, your doctor will need to<br />monitor you when you start or stop taking Sesmo.<br />&bull; Medicines that are used to thin your blood, such as warfarin. Your doctor may need<br />to monitor you when you start or stop taking Sesmo.<br />&bull; Cilostazol )used to treat intermittent claudication &ndash; a pain in your legs when you<br />walk which is caused by an insufficient blood supply(.<br />&bull; Cisapride )used for indigestion and heartburn(.<br />&bull; Digoxin )used for heart problems(.<br />&bull; Methotrexate )a chemotherapy medicine used in high doses to treat cancer( &ndash; if<br />you are taking a high dose of methotrexate, your doctor may temporarily stop your<br />Sesmo treatment.<br />&bull; Tacrolimus )organ transplantation(.<br />&bull; Rifampicin )used for treatment of tuberculosis(.<br />&bull; St. John&rsquo;s wort )Hypericum perforatum( )used to treat depression(.<br />If your doctor has prescribed the antibiotics amoxicillin and clarithromycin as well<br />as Sesmo to treat ulcers caused by Helicobacter pylori infection, it is very important<br />that you tell your doctor about any other medicines you are taking.<br /><strong>Sesmo with food and drink</strong><br />You can take your capsules with food or on an empty stomach.<br /><strong>Pregnancy, breast-feeding and fertility</strong><br />If you are pregnant, think you may be pregnant or are planning to have a baby, ask<br />your doctor or pharmacist for advice before taking this medicine. Your doctor will<br />decide whether you can take Sesmo during this time. It is not known if Sesmo passes<br />into breast milk. Therefore, you should not take Sesmo if you are breastfeeding.<br /><strong>Driving and using machines</strong><br />Sesmo is not likely to affect you being able to drive or use any tools or machines.<br />However, side effects such as dizziness and blurred vision may uncommonly or rarely<br />occur )see section 4(. If affected, you should not drive or use machines.<br /><strong>Important Information<br />Sesmo contains sucrose</strong><br />If you have been told by your doctor that you have an intolerance to some sugars,<br />talk to your doctor before taking this medicine.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Always take this medicine exactly as your doctor or pharmacist has told you.<br />Check with your doctor or pharmacist if you are not sure.</strong><br />&bull; If you are taking this medicine for a long time, your doctor will want to monitor you<br />)particularly if you are taking it for more than a year(.<br />&bull; If your doctor has told you to take this medicine as and when you need it, tell your<br />doctor if your symptoms change.<br /><strong>How much to take</strong><br />&bull; Your doctor will tell you how many capsules to take and how long to take them for.<br />This will depend on your condition, how old you are and how well your liver works.<br />&bull; The recommended doses are given below.<br /><strong>Adults aged 18 and above<br />To treat heartburn caused by gastro-oesophageal reflux disease )GORD(:</strong><br />&bull; If your doctor has found that your food pipe )esophagus( has been slightly<br />damaged, the recommended dose is one Sesmo 40 mg capsule once a day for 4<br />weeks. Your doctor may tell you to take the same dose for a further 4 weeks if your<br />esophagus has not yet healed.<br />&bull; The recommended dose once the esophagus has healed is one Sesmo 20 mg<br />capsule once a day<br />&bull; If your esophagus has not been damaged, the recommended dose is one Sesmo 20<br />mg capsule each day. Once the condition has been controlled, your doctor may tell<br />you to take your medicine as and when you need it, up to a maximum of one Sesmo<br />20 mg capsule each day.<br />&bull; If you have severe liver problems, your doctor may give you a lower dose.<br /><strong>To treat ulcers caused by Helicobacter pylori infection and to stop them<br />coming back:</strong><br />&bull; The recommended dose is one Sesmo 20 mg capsule twice a day for one week.<br />&bull; Your doctor will also tell you to take antibiotics for example amoxicillin and<br />clarithromycin.<br /><strong>To treat stomach ulcers caused by NSAIDs )Non-Steroidal Anti-Inflammatory Drugs(:</strong><br />&bull; The recommended dose is one Sesmo 20 mg capsule once a day for 4 to 8 weeks.<br /><strong>To prevent stomach ulcers if you are taking NSAIDs )Non-Steroidal AntiInflammatory Drugs(:</strong><br />&bull; The recommended dose is one Sesmo 20 mg capsule once a day.<br /><strong>To treat too much acid in the stomach caused by a growth in the pancreas<br />)Zollinger-Ellison syndrome(:</strong><br />&bull; The recommended dose is Sesmo 40 mg twice a day.<br />&bull; Your doctor will adjust the dose depending on your needs and will also decide how<br />long you need to take the medicine for. The maximum dose is 80 mg twice a day.<br /><strong>Prolonged treatment after prevention of rebleeding of ulcers with intravenous<br />esomeprazole:</strong><br />The usual dose is one Sesmo 40 mg capsule once a day for 4 weeks.<br /><strong>Adolescents aged 12 or above</strong><br /><strong>To treat heartburn caused by gastro-oesophageal reflux disease )GORD(:</strong><br />&bull; If your doctor has found that your food pipe )esophagus( has been slightly<br />damaged, the recommended dose is one Sesmo 40 mg capsule once a day for 4<br />weeks. Your doctor may tell you to take the same dose for a further 4 weeks if your<br />esophagus has not yet healed.<br />&bull; The recommended dose once the esophagus has healed is one Sesmo 20 mg<br />capsule once a day.<br />&bull; If your esophagus has not been damaged, the recommended dose is one Sesmo 20<br />mg capsule each day.<br />&bull; If you have severe liver problems, your doctor may give you a lower dose.<br /><strong>To treat ulcers caused by Helicobacter pylori infection and to stop them<br />coming back:</strong><br />&bull; The recommended dose is one Sesmo 20 mg capsule twice a day for one week.<br />&bull; Your doctor will also tell you to take antibiotics for example amoxicillin and<br />clarithromycin.<br /><strong>Taking this medicine</strong><br />&bull; You can take your capsules at any time of the day.<br />&bull; You can take your capsules with food or on an empty stomach.<br />&bull; Swallow your capsules whole with a drink of water. Do not chew or crush the<br />capsules. This is because the capsules contain coated pellets which stop the<br />medicine from being broken down by the acid in your stomach. It is important not<br />to damage the pellets.<br /><strong>What to do if you have trouble swallowing the capsules</strong><br />&bull; If you have trouble swallowing the capsules:<br />- Empty them into a GLASS of still )non-fizzy( water. Do not use any other liquids.<br />- Stir )the mixture will not be clear(. Then drink the mixture straight away or within<br />30 minutes. Always stir the mixture just before drinking it.<br />- To make sure that you have drunk all of the medicine, rinse the glass very well<br />with half a glass of water and drink it. The solid pieces contain the medicine - do<br />not chew or crush them.<br />&bull; If you cannot swallow at all, the capsule content can be mixed with some water<br />and put into a syringe. It can then be given to you through a tube directly into your<br />stomach )&lsquo;gastric tube&rsquo;(.<br /><strong>Children under the age of 12 years</strong><br />Sesmo capsules are not recommended for children less than 12 years old.<br /><strong>Elderly</strong><br />Dose adjustment is not required in the elderly<br /><strong>If you take more Sesmo than you should</strong><br />If you take more Sesmo than prescribed by your doctor, talk to your doctor or<br />pharmacist straight away.<br /><strong>If you forget to take Sesmo</strong><br />If you forget to take a dose, take it as soon as you remember it. However, if it is<br />almost time for your next dose, skip the missed dose.<br />Do not take a double dose )two doses at the same time( to make up for a forgotten<br />dose.<br /><strong>If you have any further questions on the use of this medicine, ask your doctor<br />or pharmacist.</strong><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets<br />them.<br /><strong>If you notice any of the following serious side effects, stop taking Sesmo and<br />contact a doctor immediately:</strong><br />&bull; Sudden wheezing, swelling of your lips, tongue and throat or body, rash, fainting or<br />difficulties in swallowing )severe allergic reaction(.<br />&bull; Reddening of the skin with blisters or peeling. There may also be severe blisters<br />and bleeding in the lips, eyes, mouth, nose and genitals. This could be &lsquo;StevensJohnson syndrome&rsquo; or &lsquo;toxic epidermal necrolysis&rsquo;.<br />&bull; Yellow skin, dark urine and tiredness, which can be symptoms of liver problems.<br />These effects are rare, and may affect up to 1 in 1,000 people.<br /><strong>Other side effects include:</strong><br /><strong>Common )may affect up to 1 in 10 people(</strong><br />&bull; Headache.<br />&bull; Effects on your stomach or gut: diarrhoea, stomach pain, constipation, wind<br />)flatulence(.<br />&bull; Feeling sick )nausea( or being sick )vomiting(.<br />&bull; Benign polyps in the stomach<br /><strong>Uncommon )may affect up to 1 in 100 people(</strong><br />&bull; Swelling of the feet and ankles.<br />&bull; Disturbed sleep )insomnia(.<br />&bull; Dizziness, tingling feelings such as &ldquo;pins and needles&rdquo;, feeling sleepy.<br />&bull; Spinning feeling )vertigo(.<br />&bull; Dry mouth.<br />&bull; Changes in blood tests that check how the liver is working.<br />&bull; Skin rash, lumpy rash )hives( and itchy skin.<br />&bull; Fracture of the hip, wrist or spine )if Sesmo is used in high doses and over long<br />duration(.<br /><strong>Rare )may affect up to 1 in 1,000 people(</strong><br />&bull; Blood problems such as a reduced number of white cells or platelets. This can cause<br />weakness, bruising or make infections more likely.<br />&bull; Low levels of sodium in the blood. This may cause weakness, being sick )vomiting(<br />and cramps.<br />&bull; Feeling agitated, confused or depressed.<br />&bull; Taste changes.<br />&bull; Eyesight problems such as blurred vision.<br />&bull; Suddenly feeling wheezy or short of breath )bronchospasm(.<br />&bull; An inflammation of the inside of the mouth.<br />&bull; An infection called &ldquo;thrush&rdquo; which can affect the gut and is caused by a fungus.<br />&bull; Liver problems, including jaundice which can cause yellow skin, dark urine, and<br />tiredness.<br />&bull; Hair loss )alopecia(.<br />&bull; Skin rash on exposure to sunshine.<br />&bull; Joint pains )arthralgia( or muscle pains )myalgia(.<br />&bull; Generally feeling unwell and lacking energy.<br />&bull; Increased sweating.<br /><strong>Very rare )may affect up to 1 in 10,000 people(</strong><br />&bull; Changes in blood count including agranulocytosis )lack of white blood cells(<br />&bull; Aggression.<br />&bull; Seeing, feeling or hearing things that are not there )hallucinations(.<br />&bull; Severe liver problems leading to liver failure and inflammation of the brain.<br />&bull; Sudden onset of a severe rash or blistering or peeling skin. This may be associated<br />with a high fever and joint pains )Erythema multiform, Stevens-Johnson syndrome,<br />toxic epidermal necrolysis(.<br />&bull; Muscle weakness.<br />&bull; Severe kidney problems.<br />&bull; Enlarged breasts in men.<br /><strong>Not known )frequency cannot be estimated from the available data(</strong><br />&bull; If you are on Sesmo for more than three months it is possible that the levels of<br />magnesium in your blood may fall. Low levels of magnesium can be seen as fatigue,<br />involuntary muscle contractions, disorientation, convulsions, dizziness or increased<br />heart rate. If you get any of these symptoms, please tell your doctor promptly. Low<br />levels of magnesium can also lead to a reduction in potassium or calcium levels in<br />the blood. Your doctor may decide to perform regular blood tests to monitor your<br />levels of magnesium.<br />&bull; Inflammation in the gut )leading to diarrhoea(.<br />&bull; Rash, possibly with pain in the joints.<br />Sesmo may in very rare cases affect the white blood cells leading to immune<br />deficiency. If you have an infection with symptoms such as fever with a severely<br />reduced general condition or fever with symptoms of a local infection such as pain<br />in the neck, throat or mouth or difficulties in urinating, you must consult your doctor<br />as soon as possible so that a lack of white blood cells )agranulocytosis( can be ruled<br />out by a blood test. It is important for you to give information about your medication<br />at this time.<br /><strong>If any of the side effects gets serious, or if you notice any side effects not<br />listed in this leaflet, Please tell your doctor or pharmacist.</strong><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep out of the reach and sight of children.<br />- Store below 30&deg;C.<br />- Store in the original pack to protect from moisture.<br />- Do not use after the expiry date printed on the package<br />- Medicines should not be disposed of via wastewater or household waste. Ask your<br />pharmacist how to dispose of medicines no longer required. These measures will<br />help to protect the environment<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>The active ingredient is</strong> Esomeprazole.<br />Each capsule contains Esomeprazole Magnesium Trihydrate equivalent to<br />Esomeprazole 20 mg or 40 mg.<br /><strong>Other ingredients are</strong>: Hard gelatin capsule Sugar Spheres, HydroxyPropyl<br />Methylcellulose, Sodium Hydroxide, Titanium Dioxide, Talc, Methacrylic Acid<br />Copolymer, Diethyl Phthalate, Polysorbate 80 )Tween 80(.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                • Sesmo 20 mg: Capsule with White body imprint "SJ" and Yellow to light orange cap
imprint "40C", filled with white to off-white spherical pellets.
• Sesmo 40 mg: Capsule with Orange body imprint "SJ" and Olive green cap imprint
"09C", filled with white to off-white spherical pellets.
Pack:
• Sesmo 20 mg: 28 Capsules, 4 strips )7 Capsules/Strip( & 14 Capsules, 2 strips )7
Capsules/Strip(
• Sesmo 40 mg: 28 Capsules, 4 strips )7 Capsules /Strip( & 14 Capsules, 2 strips )7
Capsules/Strip(
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>SAJA Pharmaceuticals</strong><br />Saudi Arabian Japanese pharmaceutical company limited<br />Jeddah &ndash; Kingdom of Saudi Arabia<br />&nbsp;</p><p><strong>-To report any side effect )s(</strong><br /><strong>&bull; Saudi Arabia</strong><br />- The National Pharmacovigilance Centre )NPC(:<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: https://ade.sfda.gov.sa<br /><strong>&bull; Other GCC States and other Countries:</strong><br />- Please contact the relevant competent authority<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                June/2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>&quot;ســيزمو يحتــوي علــى دواء يســمى إيســوميبرازول. هــذا ينتمــي إلــى مجموعــة مــن الأدويــة تســمى<br />&quot;مثبطــات مضخــة البروتــون.&quot; وهــي تعمــل عــن طريــق تقليــل كميــة الحامــض التــي تنتجهــا معدتــك.<br />يستخدم سيزمو لعاج الحالات التالية:<br /><strong>الكبار</strong><br />&bull; &quot; الارتجـاع المعـدي المريئـي&quot; ( .)GORDيحـدث عنـد ارتجـاع الحمـض مـن المعـدة إلـى المـريء (الأنبـوب<br />الـذي يربـط الحلـق بالمعـدة) ممـا يسـبب الألـم والالتهـاب والحرقـة.<br />&bull; قــرح فــي المعــدة أو الجــزء العلــوي مــن القنــاة الهضميــة (الأمعــاء) التــي تصــاب ببكتيريــا تســمى<br />&quot;هيليكوباكتــر بيلــوري.&quot; إذا كان لديــك هــذه الحالــة، قــد يصــف الطبيــب أيضــا المضــادات الحيويــة لعــاج<br />العــدوى وإعطــاء الفرصــة لشــفاء القرحــة.<br />&bull; قرحـة المعـدة التـي تسـببها الأدويـة التـي تسـمى مضـادات الالتهـاب غيـر السـتيرويدية. سـيزمو يمكـن<br />أن يسـتخدم أيضـا لإيقـاف تكـون تقرحـات المعـدة إذا كنـت تأخـذ مضـادات الالتهـاب غيـر السـتيرويدية.<br />&bull; كثرة الحمض الموجود في المعدة الناجمة عن تورم في البنكرياس (متازمة زولينجر إليسون.)<br />&bull; العاج لفترة طويلة بعد منع عودة النزف من القرحة بعد استخدام إيسوميبرازول الوريدي.<br /><strong>المراهقين الذين تتراوح أعمارهم بين 1٢سنة وما فوق</strong><br />&bull; &quot;مـرض ارتجـاع المـريء&quot; ( .)GORDيحـدث هـذا عندمـا يهـرب الحمـض مـن المعـدة إلـى المـريء (الأنبـوب<br />الـذي يربـط الحلـق إلـى معدتـك) ممـا يسـبب الألـم والالتهـاب والحرقـة.<br />&bull; قــرح فــي المعــدة أو الجــزء العلــوي مــن القنــاة الهضميــة (الأمعــاء) التــي تصــاب ببكتيريــا تســمى<br />&quot;هيليكوباكتــر بيلــوري.&quot; إذا كان لديــك هــذه الحالــة، قــد يصــف الطبيــب أيضــا المضــادات الحيويــة لعــاج<br />العــدوى والســماح للقرحــة بالشــفاء</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تتناول سيزمو :</strong><br />&bull; إذا كان لديــك حساســية مــن إيســوميبرازول أو أي مــن المكونــات الأخــرى مــن هــذا الــدواء (المدرجــة<br />فــي القســم .)6<br />&bull; إذا كان لديـك حساسـية مـن الأدويـة الأخـرى مثبطـات مضخـة البروتـون (مثـل بانتوبـرازول، لانزوبـرازول،<br />رابيبـرازول، أوميبـرازول.)<br />&bull; إذا كنت تتناول دواء يحتوي على نلفينافير (المستخدم لعاج عدوى فيروس نقص المناعة البشرية.)<br />لا تتنـاول سـيزمو إذا كان أي ممـا سـبق ينطبـق عليـك. إذا لـم تكـن متأكـدا، تحـدث مـع طبيبـك أو الصيدلـي<br />قبـل تناول سـيزمو.<br /><strong>الاحتياطات عند تناول سيزمو</strong><br />تحدث مع طبيبك أو الصيدلاني قبل تناول سيزمو :<br />&bull; إذا كنت تعاني من مشاكل خطيرة في الكبد.<br />&bull; إذا كنت تعاني من مشاكل خطيرة في الكلى.<br />&bull; إذا كان لديـك فـي أي وقـت مضـى ردة فعـل بالجلـد بعـد العـاج بـدواء مماثـل لسـيزمو والـذي يقلـل<br />مـن حمـض المعـدة.<br />&bull; إذا كان من المقرر أن يكون لديك فحص دم معين (كروموغرانين .)A<br />&bull; إذا كان لديك نقص فيتامين ب . 12<br />سـيزمو قـد يخفـي أعـراض الأمـراض الأخـرى. لذلـك، إذا كان أي مـن الأعـراض التاليـة يحـدث لـك قبـل البـدء<br />فـي تنـاول سـيزمو أو أثنـاء تناولـه، تحـدث مـع طبيبـك علـى الفـور:<br />&bull; تفقد الكثير من الوزن دون سبب ولديك مشاكل في البلع.<br />&bull; يحدث لك آلام في المعدة أو عسر الهضم.<br />&bull; بدأت في تقيؤ الطعام أو دم.<br />&bull; تخرج براز أسود (البراز الملطخة بالدم.)<br />* إذا تـم وصـف سـيزمو لـك &quot;عنـد الحاجـة&quot; يجـب عليـك الاتصـال بطبيبـك إذا اسـتمرت الأعـراض التـي تحـدث<br />لـك أو تغيـرت فـي طابعهـا.<br />* تنـاول مثبـط مضخـة البروتـون مثـل سـيزمو ، وخاصـة علـى مـدى فتـرة أكثـر مـن سـنة واحـدة، قـد يزيـد<br />قليــا مــن خطــر الكســور فــي عظــام الــورك والمعصــم أو العمــود الفقــري. أخبــر طبيبــك إذا كان لديــك<br />هشاشـة العظـام أو إذا كنـت تأخـذ السـتيرويدات (التـي يمكـن أن تزيـد مـن خطـر هشاشـة العظـام.)<br />* إذا حـدث لـك طفـح علـى جلـدك، وخاصـة فـي المناطـق المعرضـة لأشـعة الشـمس أخبـر طبيبـك بأسـرع<br />مـا يمكـن، كمـا أنـك قـد تحتـاج إلـى إيقـاف عاجـك بسـيزمو. تذكـر أن تخبـر طبيبـك أيضـا عـن أي آثـار سـيئة<br />أخـرى مثـل الألـم فـي المفاصـل.<br /><strong>الأدوية الأخرى و سيزمو</strong><br />أخبــر طبيبــك أو الصيدلــي إذا كنــت تتنــاول، قــد تناولــت مؤخــرا أو قــد تتنــاول أي أدويــة أخــرى. وهــذا<br />يشـمل الأدويـة التـي تشـتريها بـدون وصفـة طبيـة. وذلـك لأن سـيزمو يمكـن أن يؤثـر علـى طريقـة عمـل<br />بعــض الأدويــة وبعــض الأدويــة يمكــن أن يكــون لهــا تأثيــر علــى ســيزمو .<br />لا تتنــاول كبســولات ســيزمو إذا كنــت تتنــاول دواء يحتــوي علــى نلفينافيــر (يســتخدم لعــاج عــدوى<br />فيــروس نقــص المناعــة البشــرية.)<br />أخبر طبيبك أو الصيدلي إذا كنت تتناول أي من الأدوية التالية:<br />&bull; اتازانافير (المستخدم لعاج عدوى فيروس نقص المناعة البشرية.)<br />&bull; كلوبيدوغريل (يستخدم لمنع جلطات الدم.)<br />&bull; كيتوكونازول، إيتراكونازول أو فوريكونازول (يستخدم لعاج الالتهابات الناجمة عن الفطريات.)<br />&bull; إرلوتينيب (يستخدم لعاج السرطان.)<br />&bull; سيتالوبرام، إيميبرامين أو كلوميبرامين (يستخدم لعاج الاكتئاب.)<br />&bull; الديازيبام (يستخدم لعاج القلق، واسترخاء العضات أو في الصرع.)<br />&bull; الفينيتويــن (يســتخدم فــي الصــرع.) إذا كنــت تتنــاول الفينيتويــن، ســيحتاج طبيبــك إلــى ماحظتــك عنــد<br />البــدء أو التوقــف عــن تنــاول ســيزمو .<br />&bull; الأدويـة التـي تسـتخدم لتقليـل لزوجـة الـدم، مثـل الوارفاريـن. قـد يحتـاج طبيبـك إلـى مراقبتـك عنـد البـدء<br />أو التوقـف عـن تنـاول سـيزمو .<br />&bull; سيلوســتازول (يســتخدم لعــاج العــرج المتقطــع - ألــم فــي ســاقيك عنــد المشــي الــذي يســببه عــدم<br />كفايــة إمــدادات الــدم.)<br />&bull; سيسابريد (يستخدم لعسر الهضم والحرقة.)<br />&bull; ديجوكسين (يستخدم لمشاكل القلب.)<br />&bull; ميثوتريكسـيت (وهـو دواء كيميائـي يسـتخدم بجرعـات عاليـة لعـاج السـرطان) - إذا كنـت تتنـاول جرعـة<br />عاليـة مـن الميثوتريكسـيت، قـد يوقـف طبيبـك اسـتخدامك لعـاج سـيزمو مؤقتـا.<br />&bull; تاكروليموس (يستخدم في زرع الأعضاء.)<br />&bull; ريفامبيسين (يستخدم لعاج السل.)<br />&bull; نبتة سانت جون (هيبيريكوم بيرفوراتوم) (تستخدم لعاج الاكتئاب.)<br />إذا كان طبيبـك قـد وصـف المضـادات الحيويـة أموكسيسـيلين و كاريثروميسـين وكذلـك سـيزمو لعـاج<br />القرحـة الناجمـة عـن عـدوى هيليكوباكتـر بيلـوري، فمـن المهـم جـدا أن تخبـر طبيبـك عـن أي أدويـة أخـرى<br />كنـت تتناولهـا.<br /><strong>تناول سيزمو مع الطعام والشراب</strong><br />يمكنك أن تتناول كبسولاتك مع الطعام أو على معدة فارغة.<br /><strong>الحمل والرضاعة الطبيعية والخصوبة</strong><br />إذا كنتــي حامــا، تعتقديــن أنــك قــد تكونيــن حامــا أو تخططيــن لــولادة طفــل، اطلبــي مــن الطبيــب أو<br />الصيدلـي الحصـول علـى المشـورة قبـل تنـاول هـذا الـدواء. سـوف يقـرر طبيبـك مـا إذا كان بإمكانـك تنـاول<br />سـيزمو خـال هـذا الوقـت. ومـن غيـر المعـروف مـا إذا كان سـيزمو يفـرز مـع حليـب الثـدي. لذلـك، يجـب ألا<br />تأخـذي سـيزمو إذا كنتـي ترضعيـن طفلـك رضاعـة طبيعيـة.<br /><strong>القيادة واستخدام الآلات</strong><br />ليـس مـن المرجـح أن يؤثـر سـيزمو فـي القـدرة علـى قيـادة أو اسـتخدام أي أدوات أو آلات. ومـع ذلـك،<br />قـد تحـدث آثـار جانبيـة مثـل الدوخـة وعـدم وضـوح الرؤيـة بشـكل نـادر أو غيـر معتـاد (انظـر القسـم .)4إذا<br />تأثـرت، يجـب ألا تقـود سـيارة أو تسـتخدم الآلات.<br /><strong>معلومات هامة<br />سيزمو يحتوي على السكروز</strong><br />إذا قيــل لــك مــن قبــل طبيبــك أن لديــك عــدم تحمــل لبعــض الســكريات، تحــدث إلــى طبيبــك قبــل تنــاول<br />هــذا الــدواء<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>دائمــا تنــاول هــذا الــدواء تمامــا كمــا قــال لــك الطبيــب أو الصيدلــي. تحقــق مــن طبيبــك أو<br />الصيدلــي إذا كنــت غيــر متأكــد.</strong><br />&bull; إذا كنـت تتنـاول هـذا الـدواء لفتـرة طويلـة، فسـوف يـود طبيبـك أن ياحظـك (خاصـة إذا كنـت تتنـاول<br />الـدواء لمـدة تزيـد عـن عـام.)<br />&bull; إذا أخبرك طبيبك بأن تتناول هذا الدواء عند الحاجة، أخبر طبيبك إذا تغيرت الأعراض.<br />الجرعة<br />&bull; ســوف يخبــرك طبيبــك بعــدد الكبســولات التــي يجــب أخذهــا ومــدة أخذهــا. هــذا يعتمــد علــى حالتــك،<br />كـم عمـرك وجـودة عمـل الكبـد.<br />&bull; يتم إعطاء الجرعات الموصى بها كالتالي:<br /><strong>البالغين الذين أعمارهم من عمر 18عاما فما فوق</strong><br /><strong>لعلاج حرقة المعدة الناجمة عن مرض الارتجاع المعدي المريئي (:)GORD</strong><br />&bull; إذا وجـد طبيبـك أن أنبـوب الطعـام لديـك (المـريء) قـد أصيـب بأضـرار طفيفـة، فـإن الجرعـة الموصـى<br />بهـا هـي كبسـولة واحـدة مـن سـيزمو 40ملـج مـرة واحـدة يوميـا لمـدة 4أسـابيع. قـد يخبـرك طبيبـك أن<br />تأخـذ نفـس الجرعـة لمـدة 4أسـابيع أخـرى إذا لـم يلتئـم المـريء لديـك.<br />&bull; الجرعـة الموصـى بهـا بمجـرد أن يلتئـم المـريء هـي كبسـولة واحـدة مـن سـيزمو 20ملـج مـرة واحـدة<br />فـي اليـوم<br />&bull; إذا لـم يتـم تلـف المـريء، الجرعـة الموصـى بهـا هـي كبسـولة واحـدة مـن سـيزمو 20ملـج واحـدة يوميا.<br />وبمجـرد أن يتـم التحكـم فـي الحالـة، قـد يخبـرك الطبيـب بـأن تتنـاول الـدواء عنـد الحاجـة إليـه، بحـد أقصـى<br />كبسـولة سـيزمو 20ملـج واحـدة يوميـا.<br />&bull; إذا كنت تعاني من مشاكل شديدة في الكبد، قد يعطيك الطبيب جرعة أقل.<br /><strong>لعلاج القرحة التي تسببها عدوى هيليكوباكتر بيلوري وإيقاف عودتها:</strong><br />&bull; الجرعة الموصى بها هي كبسولة واحدة من سيزمو 20ملج مرتين في اليوم لمدة أسبوع واحد.<br />&bull; ســوف يخبــرك طبيبــك أيضــا بتنــاول المضــادات الحيويــة علــى ســبيل المثــال أموکسیســیلین<br />و کا ر یثر و میســین .<br /><strong>لعــلاج قرحــة المعــدة الناجمــة عــن مضــادات الالتهــاب غيــر الســتيرويدية (الأدويــة اللاســتيرويدية<br />المضــادة للالتهابــات:)</strong><br />&bull; الجرعــة الموصــى بهــا هــي كبســولة واحــدة مــن ســيزمو 20ملــج مــرة واحــدة فــي اليــوم لمــدة 8-4<br />أســابيع.<br /><strong>لمنـع قرحـة المعـدة إذا كنـت تأخـذ مضـادات الالتهـاب غيـر السـتيرويدية (الأدويـة اللاسـتيرويدية<br />المضـادة للالتهابـات:)</strong><br />&bull; الجرعة الموصى بها هي كبسولة واحدة من سيزمو 20ملج مرة واحدة في اليوم.<br /><strong>لعلاج كثرة حمض في المعدة الناجمة عن تورم في البنكرياس (متلازمة زولينجر إليسون:)</strong><br />&bull; الجرعة الموصى بها هي كبسولة واحدة من سيزمو 40ملج مرتين في اليوم.<br />ً &bull; سـيقوم طبيبـك بتعديـل الجرعـة تبعـا لاحتياجاتـك وسـيقرر أيضـا كـم مـن الوقـت تحتـاج لتنـاول الـدواء.<br />الجرعـة القصـوى هـي 80ملـج مرتيـن فـي اليـوم.<br /><strong>العلاج لفترة طويلة بعد منع عودة النزف من القرحة بعد استخدام إيسوميبرازول الوريدي:</strong><br />&bull; الجرعة المعتادة هي كبسولة واحدة من سيزمو 40ملج مرة واحدة في اليوم لمدة 4أسابيع.<br /><strong>المراهقين الذين أعمارهم من عمر 12 أو أعلى</strong><br /><strong>لعلاج حرقة المعدة الناجمة عن مرض ارتجاع المريء (:)GORD</strong><br />&bull; إذا وجـد طبيبـك أن أنبـوب الطعـام لديـك (المـريء) قـد أصيـب بأضـرار طفيفـة، فـإن الجرعـة الموصـى<br />بهـا هـي كبسـولة واحـدة مـن سـيزمو 40ملـج مـرة واحـدة يوميـا لمـدة 4أسـابيع. قـد يخبـرك طبيبـك أن<br />تأخـذ نفـس الجرعـة لمـدة 4أسـابيع أخـرى إذا لـم يلتئـم المـريء بعـد.<br />&bull; الجرعــة الموصــى بهــا بمجــرد شــفاء المــريء هــي كبســولة واحــدة مــن ســيزمو 20ملــج مــرة واحــدة<br />فــي اليــوم.<br />&bull; إذا لـم يتـم تلـف المـريء، فـإن الجرعـة الموصـى بهـا هـي كبسـولة واحـدة مـن سـيزمو 20ملـج مـرة<br />واحــدة كل يــوم.<br />&bull; إذا کنت تعاني من مشاکل شديدة في الکبد، قد یصف لك الطبیب جرعة أقل.<br /><strong>لعلاج القرحة التي تسببها عدوى هيليكوباكتر بيلوري وايقاف عودتها:</strong><br />&bull; الجرعة الموصى بها هي كبسولة واحدة من سيزمو 20ملج مرتين في اليوم لمدة أسبوع واحد.<br />&bull; سوف يخبرك طبيبك أيضا بأخذ المضادات الحیویة علی سبیل المثال أموکسیسیلین وکاریثرومیسین.<br /><strong>تناول هذا الدواء</strong><br />يمكنك تناول الكبسولات في أي وقت من اليوم.<br />&bull; يمكنك تناول كبسولاتك مع الطعام أو على معدة فارغة.<br />&bull; ابتـاع الكبسـولات بكاملهـا مـع المـاء. لا تمضـغ أو تسـحق الكبسـولات. وذلـك لأن الكبسـولات تحتـوي<br />علـى كريـات مغلفـة التـي تمنـع تكسـر الـدواء بواسـطة الحمـض فـي معدتـك. مـن المهـم عـدم إلحـاق<br />الضـرر بالكريـات.<br /><strong>ماذا تفعل إذا كان لديك مشكلة في بلع الكبسولات</strong><br />&bull; إذا کنت تعاني من صعوبة في بلع الكبسولات:<br />- افرغها في كوب من المياه (غير الغازية.) لا تستخدم أي سوائل أخرى.<br />- مـع التحريـك (الخليـط لـن يكـون شـفافا.) ثـم اشـرب الخليـط علـى الفـور أو فـي غضـون 30دقيقـة. دائمـا<br />حـرك الخليـط قبـل شـربه.<br />- للتأكـد مـن شـرب كل الـدواء، أشـطف الكـوب جيـدا مـع نصـف كـوب مـن المـاء واشـربه .الأجـزاء الصلبـة<br />تحتـوي علـى الـدواء لا تمضغهـا أو تسـحقها .<br />&bull; إذا كنـت لا تسـتطيع البلـع علـى الإطـاق، يمكـن خلـط محتـوى الكبسـولة مـع بعـض المـاء ووضعهـا<br />فـي حقنـة. ويمكـن بعـد ذلـك أن تعطـى لـك مـن خـال أنبـوب مباشـرة فـي المعـدة &#39;(أنبـوب المعـدة.)&#39;<br /><strong>الأطفال دون سن 12 عاما</strong><br />لا ينصح بكبسولات سيزمو للأطفال أقل من 12سنة.<br /><strong>كبار السن</strong><br />ليس من الضروري تعديل الجرعة لكبار السن.<br /><strong>إذا تناولت سيزمو أكثر مما يجب</strong><br />إذا تناولت سيزمو أكثر مما وصفه طبيبك لك، تحدث إلى طبيبك أو الصيدلي مباشرة.<br /><strong>إذا نسيت تناول أقراص سيزمو الخاصة بك</strong><br />إذا نسـيت تنـاول جرعـة، تناولهـا عنـد تذكرهـا. ومـع ذلـك، إذا حـان الوقـت تقريبـا للجرعـة التاليـة، تخطـى<br />الجرعـة الفائتـة.<br />لا تأخذ جرعة مضاعفة (جرعتان في نفس الوقت) لتعويض الجرعة المنسية.<br /><strong>إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي</strong><br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثـل جميـع الأدويـة، يمكـن أن تسـبب كبسـولات سـيزمو آثـارا جانبيـة علـى الرغـم مـن أن هـذه الآثـار لا<br />تحـدث لـكل شـخص.<br />إذا لاحظت أي من الآثار الجانبية الخطيرة التالية، توقف عن تناول سيزمو واتصل بالطبيب فورا:<br />&bull; الأزيـز المفاجـئ، وتـورم الشـفتين، واللسـان والحلـق أو الجسـم، والطفـح الجلـدي، وإغمـاء أو صعوبـات<br />فـي البلـع (ردة فعـل تحسسـية شـديدة.)<br />&bull; احمــرار الجلــد مــع ظهــور بثــور أو تقشــير. قــد يكــون هنــاك أيضــا بثــور شــديدة ونزيــف فــي الشــفتين<br />والعينيـن والفـم والأنـف والأعضـاء التناسـلية. هـذا يمكـن أن يكـون &quot;متازمـة سـتيفنز جونسـون&quot; أو &quot; تقشـر<br />الأنســجة المتموتــة البشــروية التســممي.&quot;<br />&bull; اصفرار الجلد ، البول الداكن والتعب الذي يمكن أن يكون أعراض لمشاكل الكبد.<br />هذه الآثار الجانبية نادرة، وقد تؤثر على ما يصل إلى 1من كل 1000شخص.<br /><strong>الآثار الجانبية الأخرى تتضمن:</strong><br /><strong>شائعة (قد تؤثر على ما يصل إلى 1من كل 1٠أشخاص)</strong><br />&bull; صداع الراس.<br />&bull; آثار على معدتك أو الأمعاء: الإسهال، آلام في المعدة، والإمساك، والريح (انتفاخ البطن.)<br />&bull; الشعور بالمرض (الغثيان) أو الاعياء (القيء.)<br />&bull; الاورام الحميدة في المعدة .<br /><strong>غير شائعة (قد تؤثر على ما يصل إلى 1من كل 1٠٠شخص)</strong><br />&bull; تورم القدمين والكاحلين.<br />&bull; اضطراب النوم (الأرق.)<br />&bull; الدوخة، مشاعر وخز مثل &quot;الدبابيس والإبر،&quot; والشعور بالنعاس.<br />&bull; الشعور بالدوار.<br />&bull; جفاف الفم.<br />&bull; تغييرات في اختبارات الدم التي تتحقق من كيفية عمل الكبد.<br />&bull; طفح جلدي، طفح جلدي عقدي (أرتيكاريا) وحكة في الجلد.<br />&bull; كســر فــي الــورك، المعصــم أو العمــود الفقــري (إذا تــم اســتخدام ســيزمو فــي جرعــات عاليــة وعلــى<br />مــدى فتــرة طويلــة.)<br /><strong>نادرة (قد تؤثر على ما يصل إلى 1من كل 1٠٠٠شخص)</strong><br />&bull; مشــاكل فــي الــدم مثــل انخفــاض عــدد الخايــا البيضــاء أو الصفائــح الدمويــة. هــذا يمكــن أن يســبب<br />ضعــف، كدمــات أو جعــل الالتهابــات أكثــر احتمــالا.<br />&bull; انخفاض مستويات الصوديوم في الدم. هذا قد يسبب الضعف، والمرض (القيء) والتشنجات.<br />&bull; الشعور بالتهيج أو الخلط أو الاكتئاب.<br />&bull; تغييرات بالتذوق.<br />&bull; مشاكل البصر مثل عدم وضوح الرؤية.<br />&bull; الشعور فجأة بضيق أو قصر التنفس (تشنج قصبي.)<br />&bull; التهاب في داخل الفم.<br />&bull; عدوى تسمى &quot;القاع&quot; التي يمكن أن تؤثر على القناة الهضمية وتسببها الفطريات.<br />&bull; مشاكل بالكبد وتشمل الصفراء التي تسبب اصفرار الجلد، بول داكن والتعب.<br />&bull; فقدان الشعر (الثعلبة)<br />&bull; طفح جلدي عند التعرض للشمس<br />&bull; آلام بالمفاصل (ألم مفصلي) أو آلام بالعضات (ألم عضلي.)<br />&bull; احساس عام بالتوعك فقدان الطاقة<br />&bull; زيادة التعرق<br /><strong>نادرة جدا (قد تؤثر على ما يصل إلى 1من كل 1٠٠٠٠شخص)</strong><br />&bull; تغيرات في تعداد الدم بما في ذلك ندرة المحببات (نقص خايا الدم البيضاء)<br />&bull; العدوانية.<br />&bull; رؤية أو السمع أو الشعور بأشياء ليست موجودة (الهلوسة)<br />&bull; مشاكل الكبد الشديدة التي تؤدي إلى فشل الكبد والتهاب الدماغ.<br />&bull; ظهـور مفاجـئ لطفـح جلـدي حـاد أو تقشـير للبشـرة . هـذه قـد تترافـق مـع ارتفـاع فـي درجـة الحـرارة<br />وآلام المفاصـل (حمامـي عديـدة الأشـكال، متازمـة سـتيفنز جونسـون، تقشـر الأنسـجة المتموتـة البشـروية<br />التسـممي)<br />&bull; ضعف العضات.<br />&bull; مشاكل الكلى الشديدة.<br />&bull; تضخم الثدي في الرجال.<br /><strong>غير معروف (لا يمكن تقدير التكرار من البيانات المتاحة)</strong><br />&bull; إذا كنـت تتنـاول سـيزمو لأكثـر مـن ثاثـة أشـهر فمـن الممكـن أن تنخفـض مسـتويات المغنيسـيوم فـي<br />الــدم. يمكــن أن تــرى المســتويات المنخفضــة مــن المغنيســيوم فــي صــورة التعــب، تقلصــات العضــات<br />الاإراديـة، والارتبـاك، والتشـنجات، والدوخـة أو زيـادة معـدل ضربـات القلـب. إذا ظهـر عليـك أي مـن هـذه<br />الأعـراض، يرجـى إخبـار الطبيـب علـى وجـه السـرعة. انخفـاض مسـتويات المغنيسـيوم يمكـن أن يـؤدي أيضا<br />إلـى انخفـاض فـي مسـتويات البوتاسـيوم أو الكالسـيوم فـي الـدم. قـد يقـرر طبيبـك إجـراء فحـوص دم<br />منتظمـة لمراقبـة مسـتويات المغنيسـيوم.<br />&bull; التهاب في الأمعاء (مما يؤدي إلى الإسهال)<br />&bull; طفح جلدي، ربما مع ألم في المفاصل.<br />ً قـد تؤثـر كبسـولات سـيزمو فـي حـالات نـادرة جـدا علـى خايـا الـدم البيضـاء المؤديـة إلـى نقـص المناعـة.<br />إذا كان لديـك عـدوى مـع أعـراض مثـل الحمـى مـع انخفـاض شـديد فـي الحالـة العامـة أو الحمـى مـع<br />أعــراض عــدوى محليــة مثــل ألــم فــي الرقبــة والحلــق أو الفــم أو صعوبــات فــي التبــول، يجــب عليــك<br />استشـارة الطبيـب فـي أقـرب وقـت ممكـن بحيـث يمكـن اسـتبعاد النقـص فـي خايـا الـدم البيضـاء (نـدرة<br />المحببـات) مـن خـال اختبـار الـدم. مـن المهـم بالنسـبة لـك أن تعطـي معلومـات عـن الـدواء الخـاص بـك<br />فـي هـذا الوقـت.<br /><strong>إذا أصبحـت أي مـن الآثـار الجانبيـة خطيـرة، أو إذا لاحظـت أي آثـار جانبيـة غيـر المذكـورة فـي هـذه<br />النشـرة، يرجـى إخبـار الطبيـب أو الصيدلي.</strong><br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- يحفظ بعيدا عن متناول أيدي ونظر الأطفال.<br />- يحفظ في درجة حرارة أقل من 30درجة مئوية.<br />- يحفظ في العبوة الأصلية للحماية من الرطوبة.<br />- لا تستخدم سيزمو بعد تاريخ انتهاء الصاحية المدون على الشريط وعلى الكرتون.<br />- لا تتخلــص مــن أي أدويــة عــن طريــق ميــاه الصــرف الصحــي أو النفايــات المنزليــة. اســأل الصيدلــي عــن<br />كيفيــة التخلــص مــن الأدويــة التــي لــم تعــد مطلوبــة. هــذه التدابيــر تســاعد فــي حمايــة البيئــة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>المادة الفعالة</strong> هي إيسوميبرازول<br />حيـث تحتـوي كل كبسـولة علـى إيسـوميبرازول مغنيسـيوم ثاثـي هيـدرات مـا يعـادل إيسـوميبرازول 20<br />ملـج أو 40ملـج.<br /><strong>المكونـات الأخـرى</strong> هـي: كبسـولة جياتينيـة صلبـة, كـرات سـكرية, هيدروكسـي بروبيـل ميثيـل سـليولوز,<br />صوديـوم هيدروكسـيد, تيتانيـوم دايوكسـيد, تلـك, ميثاكريلـك أسـيد كوبوليميـر , داي ايثيـل فثـالات, بولـي<br />سـوربات ( , 80تويـن )<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>الكبسولة:<br />&bull; ســيزمو ٢٠ملــج: كبســولة لهــا غطــاء أصفــر إلــى برتقالــي فاتــح و مطبــوع عليــه &quot; &quot;40Cولهــا جســم<br />أبيــض ومطبــوع عليــه &quot;.&quot;SJ<br />&bull; سـيزمو ٤٠ملـج: كبسـولة لهـا غطـاء أخضـر زيتونـي مطبـوع عليـه &quot; &quot;09Cولهـا جسـم برتقالـي مطبـوع<br />عليـه &quot;.&quot;SJ<br />العبوة:<br />&bull; ســيزمو ٢٠ملــج: 28كبســولة، 4شــرائط ( 7كبســولة / شــريط) و 14كبســولة ، 2شــريط ( 7كبســولة<br />/ شـريط.)<br />&bull; ســيزمو ٤٠ملــج: 28كبســولة، 4شــرائط ( 7كبســولة / شــريط) و 14كبســولة ، 2شــريط ( 7كبســولة<br />/ شـريط.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>ساجا الصيدلانية</strong><br />الشركة العربية السعودية اليابانية للمنتجات الصيدلانية المحدودة<br />جدة &ndash; المملكة العربية السعودية<br />&nbsp;</p><p><strong>للإبلاغ عن الأعراض الجانبية<br />&bull; المملكة العربية السعودية</strong><br />- المركز الوطني للتيقظ والسامة الدوائية<br />- مركز اتصال هيئة الغذاء والدواء : 19999<br />npc.drug@sfda.gov.sa :- البريد الإلكتروني<br />https://ade.sfda.gov.sa :- الموقع الإلكتروني<br /><strong>&bull; دول الخليج الأخرى/ الدول الأخرى</strong><br />- الرجاء الاتصال بالمؤسسات و الهيئات الوطنية في كل دولة<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يونيو/2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sesmo Capsule 20 mg 
Sesmo Capsule 40 mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each capsule contains Esomeprazole (as pellets), Each capsule contains Esomeprazole Magnesium trihydrate equivalent to Esomeprazole 20 mg or 40 mg For full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hard gelatin capsules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults</p><p>Gastroesophageal Reflux Disease (GERD)</p><p>-&nbsp; treatment of erosive reflux esophagitis 40 mg once daily for 4 weeks.</p><p>An additional 4 weeks treatment is recommended for patients in whom esophagitis has not healed or who have persistent symptoms.</p><p>&nbsp;</p><p>-&nbsp; long-term management of patients with healed esophagitis to prevent relapse 20 mg once daily.</p><p>-&nbsp; symptomatic treatment of gastroesophageal reflux disease (GERD)</p><p>20 mg once daily in patients without esophagitis. If symptom control has not been achieved after 4 weeks, the patient should be further investigated. Once symptoms have resolved, subsequent symptom control can be achieved using 20 mg once daily. An on demand regimen taking 20 mg once daily, when needed, can be used. In NSAID treated patients at risk of developing gastric and duodenal ulcers, subsequent symptom control using an on demand regimen is not recommended.</p><p>&nbsp;</p><p>In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and</p><p>-&nbsp; healing of Helicobacter pylori associated duodenal ulcer and</p><p>-&nbsp; prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers.</p><p>&nbsp;</p><p>20 mg Sesmo with 1 g amoxicillin and 500 mg clarithromycin, all twice daily for 7 days. Patients requiring continued NSAID therapy</p><p>&nbsp;</p><p>-&nbsp; healing of gastric ulcers associated with NSAID therapy</p><p>The usual dose is 20 mg once daily. The treatment duration is 4-8 weeks.</p><p>&nbsp;</p><p>- prevention of gastric and duodenal ulcers associated with NSAID therapy in patients at risk</p><p>20 mg once daily.</p><p>Treatment of Zollinger Ellison Syndrome</p><p>The recommended initial dosage is Sesmo 40 mg twice daily. The dosage should then be individually adjusted and treatment continued as long as clinically indicated. Based on the</p><p>&nbsp;</p><p>clinical data available, the majority of patients can be controlled on doses between 80 to 160 mg esomeprazole daily. With doses above 80 mg daily, the dose should be divided and given twice-daily.</p><p>&nbsp;</p><p><u>Special Populations</u> Renal impairment</p><p>Dose adjustment is not required in patients with impaired renal function. Due to limited experience in patients with severe renal insufficiency, such patients should be treated with caution (see section 5.2).</p><p>&nbsp;</p><p>Hepatic impairment</p><p>Dose adjustment is not required in patients with mild to moderate liver impairment. For patients with severe liver impairment, a maximum dose of 20 mg Sesmo should not be exceeded (see section 5.2).</p><p>&nbsp;</p><p>Elderly</p><p>Dose adjustment is not required in the elderly. Paediatric population</p><p><u>Adolescents from the age of 12 years</u> Gastroesophageal Reflux Disease (GERD)</p><p>-&nbsp; treatment of erosive reflux esophagitis 40 mg once daily for 4 weeks.</p><p>An additional 4 weeks treatment is recommended for patients in whom esophagitis has not healed or who have persistent symptoms.</p><p>&nbsp;</p><p>-&nbsp; long-term management of patients with healed esophagitis to prevent relapse 20 mg once daily.</p><p>&nbsp;</p><p>-&nbsp; symptomatic treatment of gastroesophageal reflux disease (GERD)</p><p>20 mg once daily in patients without esophagitis. If symptom control has not been achieved after 4 weeks, the patient should be further investigated. Once symptoms have resolved, subsequent symptom control can be achieved using 20 mg once daily.</p><p>Treatment of duodenal ulcer caused by Helicobacter pylori</p><p>When selecting appropriate combination therapy, consideration should be given to official national, regional and local guidance regarding bacterial resistance, duration of treatment (Most commonly 7 days but sometimes up to 14 days), and appropriate use of antibacterial agents. The treatment should be supervised by a specialist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The posology recommendation is:</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Weight</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Posology</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>30 - 40</p><p>kg</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Combination with two antibiotics: Sesmo 20 mg, amoxicillin 750 mg and clarithromycin</p><p>7.5 mg/kg body weight are all administered together twice daily for one week.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>&gt; 40 kg</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Combination with two antibiotics: Sesmo 20 mg, amoxicillin 1 g and clarithromycin 500 mg are all administered together twice daily for one week.</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>Children below the age of 12 years</strong></p><p>Sesmo should not be used in children younger than 12 years since no data is available.</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>&nbsp;</p><p>The capsules should be swallowed whole with some water. The capsules should not be chewed or crushed.</p><p>For patients who have difficulty in swallowing, the capsules can also be opened and the pellets mixed in half a glass of non-carbonated water. No other liquids should be used as the enteric coating may be dissolved. Drink the water with the pellets immediately or within 30 minutes. Rinse the glass with half a glass of water and drink. The pellets must not be chewed or crushed. For patients who cannot swallow, the capsules can be opened and pellets mixed in non- carbonated water and administered through a gastric tube. It is important that the appropriateness of the selected syringe and tube is carefully tested before use (see section 6.6).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to substituted benzimidazoles or to any of the excipients listed in section 6.1. Esomeprazole should not be used concomitantly with nelfinavir (see section 4.5).
 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the presence of any alarm symptom (e.g. significant unintentional weight loss, recurrent vomiting, dysphagia, haematemesis or melaena) and when gastric ulcer is suspected or present, malignancy should be excluded, as treatment with Sesmo may alleviate symptoms and delay diagnosis.</p><p><u>Long term use</u></p><p>Patients on long-term treatment (particularly those treated for more than a year) should be kept under regular surveillance.</p><p><u>On demand treatment</u></p><p>Patients on on-demand treatment should be instructed to contact their physician if their symptoms change in character.</p><p><u>Helicobacter pylori eradication</u></p><p>When prescribing esomeprazole for eradication of Helicobacter pylori, possible drug interactions for all components in the triple therapy should be considered. Clarithromycin is a potent inhibitor of CYP3A4 and hence contraindications and interactions for clarithromycin should be considered when the triple therapy is used in patients concurrently taking other drugs metabolized via CYP3A4 such as cisapride.</p><p><u>Gastrointestinal infections</u></p><p>Treatment with proton pump inhibitors may lead to slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter (see section 5.1).</p><p><u>Absorption of vitamin B12</u></p><p>Esomeprazole, as all acid-blocking medicines, may reduce the absorption of vitamin B12 (cyanocobalamin) due to hypo- or achlorhydria. This should be considered in patients with reduced body stores or risk factors for reduced vitamin B12 absorption on long-term therapy. <u>Hypomagnesaemia</u></p><p>Severe hypomagnesaemia has been reported in patients treated with proton pump inhibitors (PPIs) like esomeprazole for at least three months, and in most cases for a year. Serious manifestations of hypomagnesaemia such as fatigue, tetany, delirium, convulsions, dizziness and ventricular arrhythmia can occur but they may begin insidiously and be overlooked. In most affected patients, hypomagnesaemia improved after magnesium replacement and discontinuation of the PPI.</p><p>For patients expected to be on prolonged treatment or who take PPIs with digoxin or drugs that may cause hypomagnesaemia (e.g. diuretics), healthcare professionals should consider measuring magnesium levels before starting PPI treatment and periodically during treatment. <u>Risk of fracture</u></p><p>Proton pump inhibitors, especially if used in high doses and over long durations (&gt;1 year), may modestly increase the risk of hip, wrist and spine fracture, predominantly in the elderly or in presence of other recognized risk factors. Observational studies suggest that proton pump inhibitors may increase the overall risk of fracture by 10-40%. Some of this increase may be due to other risk factors. Patients at risk of osteoporosis should receive care according to current clinical guidelines and they should have an adequate intake of vitamin D and calcium.</p><p><u>Subacute cutaneous lupus erythematosus (SCLE)</u></p><p>Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping Sesmo.</p><p>&nbsp;</p><p>SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors.</p><p><u>Combination with other medicinal products</u></p><p>Co-administration of esomeprazole with atazanavir is not recommended (see section 4.5). If the combination of atazanavir with a proton pump inhibitor is judged unavoidable, close clinical monitoring is recommended in combination with an increase in the dose of atazanavir to 400 mg with 100 mg of ritonavir; esomeprazole 20 mg should not be exceeded.</p><p>&nbsp;</p><p>Esomeprazole is a CYP2C19 inhibitor. When starting or ending treatment with esomeprazole, the potential for interactions with drugs metabolized through CYP2C19 should be considered. An interaction is observed between clopidogrel and esomeprazole (see section 4.5). The clinical relevance of this interaction is uncertain. As a precaution, concomitant use of esomeprazole and clopidogrel should be discouraged.</p><p>&nbsp;</p><p>When prescribing esomeprazole for on demand therapy, the implications for interactions with other pharmaceuticals, due to fluctuating plasma concentrations of esomeprazole should be considered. See section 4.5.</p><p>&nbsp;</p><p><u>Serious cutaneous adverse reactions (SCARs)</u></p><p>Serious cutaneous adverse reactions (SCARs) such as erythema multiforme (EM), StevensJohnson syndrome (SJS), toxic epidermal necrolysis (TEN) and drug reaction with eosinophilia and systemic symptoms (DRESS), which can be life-threatening, have been reported very rarely in association with esomeprazole treatment.</p><p>&nbsp;</p><p>Patients should be advised of the signs and symptoms of the severe skin reaction EM/SJS/TEN/DRESS and should seek medical advice from their physician immediately when observing any indicative signs or symptoms.</p><p>&nbsp;</p><p>Esomeprazole should be discontinued immediately upon signs and symptoms of severe skin reactions and additional medical care/close monitoring should be provided as needed.</p><p>Re-challenge should not be undertaken in patients with EM/SJS/TEN/DRESS. <u>Sucrose</u></p><p>This medicinal product contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.</p><p>Sodium</p><p>This medicine contains less than 1 mmol sodium (23 mg) per capsule, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p>&nbsp;</p><p><u>Interference with laboratory tests</u></p><p>Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours. To avoid this interference, esomeprazole treatment should be stopped for at least 5 days before CgA measurements (see section 5.1). If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of proton pump inhibitor treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects of esomeprazole on the pharmacokinetics of other drugs Protease inhibitors</p><p>Omeprazole has been reported to interact with some protease inhibitors. The clinical importance and the mechanisms behind these reported interactions are not always known. Increased gastric pH during omeprazole treatment may change the absorption of the protease inhibitors. Other possible interaction mechanisms are via inhibition of CYP2C19.</p><p>For atazanavir and nelfinavir, decreased serum levels have been reported when given together with omeprazole and concomitant administration is not recommended. Co-administration of omeprazole (40 mg once daily) with atazanavir 300 mg/ritonavir 100 mg to healthy volunteers resulted in a substantial reduction in atazanavir exposure (approximately 75% decrease in AUC, Cmax and Cmin). Increasing the atazanavir dose to 400 mg did not compensate for the impact of omeprazole on atazanavir exposure. The co-administration of omeprazole (20 mg qd) with atazanavir 400 mg/ritonavir 100 mg to healthy volunteers resulted in a decrease of approximately 30% in the atazanavir exposure as compared with the exposure observed with atazanavir 300 mg/ritonavir 100 mg qd without omeprazole 20 mg qd. Co-administration of omeprazole (40 mg qd) reduced mean nelfinavir AUC, Cmax and Cmin by 36&ndash;39 % and mean AUC, Cmax and Cmin for the pharmacologically active metabolite M8 was reduced by 75-92%. Due to the similar pharmacodynamics effects and pharmacokinetic properties of omeprazole and esomeprazole, concomitant administration with esomeprazole and atazanavir is not recommended (see section 4.4) and concomitant administration with esomeprazole and nelfinavir is contraindicated (see section 4.3).</p><p>For saquinavir (with concomitant ritonavir), increased serum levels (80-100%) have been reported during concomitant omeprazole treatment (40 mg qd). Treatment with omeprazole 20 mg qd had no effect on the exposure of darunavir (with concomitant ritonavir) and amprenavir (with concomitant ritonavir). Treatment with esomeprazole 20 mg qd had no effect on the exposure of amprenavir (with and without concomitant ritonavir). Treatment with omeprazole 40 mg qd had no effect on the exposure of lopinavir (with concomitant ritonavir).</p><p>Methotrexate</p><p>When given together with PPIs, methotrexate levels have been reported to increase in some patients. In high-dose methotrexate administration a temporary withdrawal of esomeprazole may need to be considered.</p><p>Tacrolimus</p><p>Concomitant administration of esomeprazole has been reported to increase the serum levels of tacrolimus. A reinforced monitoring of tacrolimus concentrations as well as renal function (creatinine clearance) should be performed, and dosage of tacrolimus adjusted if needed.</p><p>Medicinal products with pH dependent absorption</p><p>Gastric acid suppression during treatment with esomeprazole and other PPIs might decrease or increase the absorption of medicinal products with a gastric pH dependent absorption. As with other medicinal products that decrease intragastric acidity, the absorption of medicinal products such as ketoconazole, itraconazole and erlotinib can decrease and the absorption of digoxin can increase during treatment with esomeprazole. Concomitant treatment with omeprazole (20 mg daily) and digoxin in healthy subjects increased the bioavailability of digoxin by 10% (up to 30% in two out of ten subjects). Digoxin toxicity has been rarely reported. However, caution should</p><p>&nbsp;</p><p>be exercised when esomeprazole is given at high doses in elderly patients. Therapeutic drug monitoring of digoxin should then be reinforced.</p><p>Medicinal products metabolized by CYP2C19</p><p>Esomeprazole inhibits CYP2C19, the major esomeprazole-metabolizing enzyme. Thus, when esomeprazole is combined with drugs metabolized by CYP2C19, such as diazepam, citalopram, imipramine, clomipramine, phenytoin etc., the plasma concentrations of these drugs may be increased and a dose reduction could be needed. This should be considered especially when prescribing esomeprazole for on-demand therapy.</p><p>Diazepam</p><p>Concomitant administration of 30 mg esomeprazole resulted in a 45% decrease in clearance of the CYP2C19 substrate diazepam.</p><p>Phenytoin</p><p>Concomitant administration of 40 mg esomeprazole resulted in a 13% increase in trough plasma levels of phenytoin in epileptic patients. It is recommended to monitor the plasma concentrations of phenytoin when treatment with esomeprazole is introduced or withdrawn.</p><p>Voriconazole</p><p>Omeprazole (40 mg once daily) increased voriconazole (a CYP2C19 substrate) Cmax and AUC by 15% and 41%, respectively.</p><p>Cilostazol</p><p>Omeprazole as well as esomeprazole act as inhibitors of CYP2C19. Omeprazole, given in doses of 40 mg to healthy subjects in a cross-over study, increased Cmax and AUC for cilostazol by 18% and 26% respectively, and one of its active metabolites by 29% and 69% respectively.</p><p>Cisapride</p><p>In healthy volunteers, concomitant administration of 40 mg esomeprazole resulted in a 32% increase in area under the plasma concentration-time curve (AUC) and a 31% prolongation of elimination half-life (t1/2) but no significant increase in peak plasma levels of cisapride. The slightly prolonged QTc interval observed after administration of cisapride alone, was not further prolonged when cisapride was given in combination with esomeprazole (see also section 4.4). Warfarin</p><p>Concomitant administration of 40 mg esomeprazole to warfarin-treated patients in a clinical trial showed that coagulation times were within the accepted range. However, post-marketing, a few isolated cases of elevated INR of clinical significance have been reported during concomitant treatment. Monitoring is recommended when initiating and ending concomitant esomeprazole treatment during treatment with warfarin or other coumarine derivatives.</p><p>Clopidogrel</p><p>Results from studies in healthy subjects have shown a pharmacokinetic (PK)/ pharmacodynamics (PD) interaction between clopidogrel (300 mg loading dose/75 mg daily maintenance dose) and esomeprazole (40 mg p.o.daily) resulting in decreased exposure to the active metabolite of clopidogrel by an average of 40% and resulting in decreased maximum inhibition of (ADP induced) platelet aggregation by an average of 14%.</p><p>When clopidogrel was given together with a fixed dose combination of esomeprazole 20 mg + ASA 81 mg compared to clopidogrel alone in a study in healthy subjects there was a decreased exposure by almost 40% of the active metabolite of clopidogrel. However, the maximum levels of inhibition of (ADP induced) platelet aggregation in these subjects were the same in the clopidogrel and the clopidogrel + the combined (esomeprazole + ASA) product groups.</p><p>&nbsp;</p><p>Inconsistent data on the clinical implications of a PK/PD interaction of esomeprazole in terms of major cardiovascular events have been reported from both observational and clinical studies. As a precaution concomitant use of clopidogrel should be discouraged.</p><p>Investigated medicinal products with no clinically relevant interaction Amoxicillin and quinidine</p><p>Esomeprazole has been shown to have no clinically relevant effects on the pharmacokinetics of amoxicillin or quinidine.</p><p>Naproxen or rofecoxib</p><p>Studies evaluating concomitant administration of esomeprazole and either naproxen or rofecoxib did not identify any clinically relevant pharmacokinetic interactions during short-term studies.</p><p>Effects of other medicinal products on the pharmacokinetics of esomeprazole Medicinal products which inhibit CYP2C19 and/or CYP3A4</p><p>Esomeprazole is metabolized by CYP2C19 and CYP3A4. Concomitant administration of esomeprazole and a CYP3A4 inhibitor, clarithromycin (500 mg b.i.d.), resulted in a doubling of the exposure (AUC) to esomeprazole. Concomitant administration of esomeprazole and a combined inhibitor of CYP2C19 and CYP3A4 may result in more than doubling of the esomeprazole exposure. The CYP2C19 and CYP3A4 inhibitor voriconazole increased omeprazole AUC by 280%. A dose adjustment of esomeprazole is not regularly required in either of these situations. However, dose adjustment should be considered in patients with severe hepatic impairment and if long-term treatment is indicated.</p><p>Medicinal products which induce CYP2C19 and/or CYP3A4</p><p>Drugs known to induce CYP2C19 or CYP3A4 or both (such as rifampicin and St. John&#39;s wort) may lead to decreased esomeprazole serum levels by increasing the esomeprazole metabolism. Paediatric population</p><p>Interaction studies have only been performed in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&nbsp;&nbsp;Pregnancy</strong></p><p>Clinical data on exposed pregnancies with Sesmo are insufficient. With the racemic mixture omeprazole data on a larger number of exposed pregnancies stemmed from epidemiological studies indicate no malformative nor foetotoxic effects. Animal studies with esomeprazole do not indicate direct or indirect harmful effects with respect to embryonal/foetal development. Animal studies with the racemic mixture do not indicate direct or indirect harmful effects with respect to pregnancy, parturition or postnatal development. Caution should be exercised when prescribing to pregnant women.</p><p>A moderate amount of data on pregnant women (between 300-1000 pregnancy outcomes) indicates no malformative or foeto/neonatal toxicity of esomeprazole.</p><p>Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3).</p><p><strong>Breast-feeding</strong></p><p>It is not known whether esomeprazole is excreted in human breast milk. There is insufficient information on the effects of esomeprazole in newborns/infants. Esomeprazole should not be used during breast-feeding.</p><p><strong>Fertility</strong></p><p>&nbsp;</p><p>Animal studies with the racemic mixture omeprazole, given by oral administration do not indicate effects with respect to fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Esomeprazole has minor influence on the ability to drive or use machines. Adverse reactions such as dizziness (uncommon) and blurred vision (rare) has been reported (see section 4.8). If affected patients should not drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Summary of the safety profile</p><p>Headache, abdominal pain, diarrhoea and nausea are among those adverse reactions that have been most commonly reported in clinical trials (and also from post-marketing use). In addition, the safety profile is similar for different formulations, treatment indications, age groups and patient populations. No dose-related adverse reactions have been identified.</p><p>Tabulated list of adverse reactions</p><p>The following adverse drug reactions have been identified or suspected in the clinical trials programme for esomeprazole and post-marketing. None was found to be dose-related. The reactions are classified according to frequency very common &ge;1/10; common &ge;1/100 to &lt;1/10; uncommon &ge;1/1,000 to &lt;1/100; rare &ge;1/10,000 to &lt;1/1,000; very rare &lt;1/10,000; not known (cannot be estimated from the available data).</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p>System Organ Class</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Frequency</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Undesirable Effect</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Leukopenia, thrombocytopenia</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Agranulocytosis, pancytopenia</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Immune system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Hypersensitivity reactions e.g. fever, angioedema and anaphylactic reaction/shock</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>&nbsp;</p><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Peripheral oedema</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Hyponatraemia</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Hypomagnesaemia (see section 4.4); severe hypomagnesaemia can correlate with hypocalcaemia. Hypomagnesaemia may also be associated with hypokalaemia.</p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td rowspan="3" style="vertical-align:top"><p>&nbsp;</p><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Insomnia</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Agitation, confusion, depression</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Aggression, hallucinations</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>&nbsp;</p><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Common</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Headache</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Dizziness, paraesthesia, somnolence</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Taste disturbance</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Eye disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Blurred vision</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Vertigo</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Bronchospasm</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p>&nbsp;</p><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Common</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Abdominal pain, constipation, diarrhoea, flatulence, nausea/vomiting</p><p>fundic gland polyps (benign)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Dry mouth</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Stomatitis, gastrointestinal candidiasis</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Microscopic colitis</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Increased liver enzymes</p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Hepatitis with or without jaundice</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Hepatic failure, encephalopathy in patients with pre- existing liver disease</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p>&nbsp;</p><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Dermatitis, pruritus, rash, urticaria</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Alopecia, photosensitivity</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Subacute cutaneous lupus erythematosus (see section 4.4)</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>&nbsp;</p><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Uncommon</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Fracture of the hip, wrist or spine (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Arthralgia, myalgia</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Muscular weakness</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Interstitial nephritis; in some patients renal failure has been reported concomitantly.</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Gynaecomastia</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Rare</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Malaise, increased sweating</p></td></tr></tbody></table><p><br /><!--[if mso & !supportInlineShapes & supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><span style='mso-element:field-begin;mso-field-lock:
yes'></span><span style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--><!--[if gte vml 1]><v:shapetype id="_x0000_t202"
 coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t202" style='width:467.6pt;
 height:55.7pt;mso-left-percent:-10001;mso-top-percent:-10001;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:char;
 mso-position-vertical:absolute;mso-position-vertical-relative:line;
 mso-left-percent:-10001;mso-top-percent:-10001' filled="f" strokeweight=".48pt">
 <v:textbox inset="0,0,0,0">
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoBodyText style='margin-left:11.95pt;text-indent:-6.85pt;
    line-height:13.65pt;mso-line-height-rule:exactly;mso-list:l0 level1 lfo1;
    tab-stops:12.0pt'><![if !supportLists]><span style='mso-font-width:99%'><span
    style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
    dir=LTR></span>The<span style='letter-spacing:-.55pt'> </span>National<span
    style='letter-spacing:-.2pt'> </span>Pharmacovigilance<span
    style='letter-spacing:-.3pt'> </span>Centre<span style='letter-spacing:
    -.15pt'> </span>(NPC):<o:p></o:p></p>
    <p class=MsoBodyText style='margin-top:.1pt;margin-right:0in;margin-bottom:
    0in;margin-left:11.95pt;margin-bottom:.0001pt;text-indent:-6.85pt;
    mso-list:l0 level1 lfo1;tab-stops:12.0pt'><![if !supportLists]><span
    style='mso-font-width:99%'><span style='mso-list:Ignore'>-<span
    style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
    dir=LTR></span>SFDA<span style='letter-spacing:-.4pt'> </span>Call<span
    style='letter-spacing:-.25pt'> </span>Center:<span style='letter-spacing:
    -.3pt'> </span>19999<o:p></o:p></p>
    <p class=MsoBodyText style='margin-left:11.95pt;text-indent:-6.85pt;
    mso-list:l0 level1 lfo1;tab-stops:12.0pt'><![if !supportLists]><span
    style='mso-font-width:99%'><span style='mso-list:Ignore'>-<span
    style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
    dir=LTR></span><span style='letter-spacing:-.05pt'>E-mail:</span><span
    style='letter-spacing:-.6pt'> </span><a href="mailto:npc.drug@sfda.gov.sa"><span
    style='color:windowtext;letter-spacing:-.05pt;text-decoration:none;
    text-underline:none'>npc.drug@sfda.gov.sa</span></a><o:p></o:p></p>
    <p class=MsoBodyText style='margin-left:11.95pt;text-indent:-6.85pt;
    mso-list:l0 level1 lfo1;tab-stops:12.0pt'><![if !supportLists]><span
    style='mso-font-width:99%'><span style='mso-list:Ignore'>-<span
    style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
    dir=LTR></span><span style='letter-spacing:-.05pt'>Website:</span><span
    style='letter-spacing:-.7pt'> </span><span style='letter-spacing:-.05pt'>https://ade.sfda.gov.sa</span><o:p></o:p></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap type="none"/>
 <w:anchorlock/>
</v:shape><![endif]--><img width="629" height="81" alt="Text Box: -	The National Pharmacovigilance Centre (NPC):
-	SFDA Call Center: 19999
-	E-mail: npc.drug@sfda.gov.sa
-	Website: https://ade.sfda.gov.sa
" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" /><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><v:shape id="_x0000_i1025" type="#_x0000_t75"
 style='width:467.6pt;height:55.7pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is very limited experience to date with deliberate overdose. The symptoms described in connection with 280 mg were gastrointestinal symptoms and weakness. Single doses of 80 mg esomeprazole were uneventful. No specific antidote is known. Esomeprazole is extensively plasma protein bound and is therefore not readily dialyzable. As in any case of overdose, treatment should be symptomatic and general supportive measures should be utilized.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Drugs for acid-related disorders proton pump inhibitors ATC Code: A02BC05</p><p>&nbsp;</p><p>Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. Both the R- and S-isomer of omeprazole have similar pharmacodynamics activity.</p><p>Mechanism of action</p><p>Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+K+-ATPase &ndash; the acid pump and inhibits both basal and stimulated acid secretion.</p><p>Pharmacodynamic effects</p><p>After oral dosing with esomeprazole 20 mg and 40 mg the onset of effect occurs within one hour. After repeated administration with 20 mg esomeprazole once daily for five days, mean peak acid output after pentagastrin stimulation is decreased 90% when measured 6&ndash;7 hours after dosing on day five.</p><p>After five days of oral dosing with 20 mg and 40 mg of esomeprazole, intragastric pH above 4 was maintained for a mean time of 13 hours and 17 hours, respectively over 24 hours in symptomatic GERD patients. The proportion of patients maintaining an intragastric pH above 4 for at least 8, 12 and 16 hours respectively were for esomeprazole 20 mg 76%, 54% and 24%.</p><p>Corresponding proportions for esomeprazole 40 mg were 97%, 92% and 56%.</p><p>Using AUC as a surrogate parameter for plasma concentration, a relationship between inhibition of acid secretion and exposure has been shown.</p><p>Healing of reflux esophagitis with esomeprazole 40 mg occurs in approximately 78% of patients after four weeks, and in 93% after eight weeks.</p><p>One week&rsquo;s treatment with esomeprazole 20 mg b.i.d. and appropriate antibiotics, results in successful eradication of H. pylori in approximately 90% of patients.</p><p>After eradication treatment for one week, there is no need for subsequent monotherapy with antisecretory drugs for effective ulcer healing and symptom resolution in uncomplicated duodenal ulcers.</p><p>&nbsp;</p><p>In a randomized, double blind, placebo-controlled clinical study, patients with endoscopically confirmed peptic ulcer bleeding characterized as Forrest Ia, Ib, IIa or IIb (9%, 43%, 38% and 10% respectively) were randomized to receive Sesmo solution for infusion (n=375) or placebo (n=389). Following endoscopic haemostasis, patients received either 80 mg esomeprazole as an intravenous infusion over 30 minutes followed by a continuous infusion of 8 mg per hour or placebo for 72 hours. After the initial 72-hour period, all patients received open label 40 mg oral Sesmo for 27 days for acid suppression. The occurrence of rebleeding within 3 days was 5.9% in the Sesmo treated group compared to 10.3% for the placebo group. At 30 days post- treatment, the occurrence of rebleeding in the Sesmo treated versus the placebo treated group was 7.7% vs 13.6%.</p><p>During treatment with antisecretory medicinal products, serum gastrin increases in response to the decreased acid secretion. Also CgA increases due to decreased gastric acidity. The increased CgA level may interfere with investigations for neuroendocrine tumours. Available published evidence suggests that proton pump inhibitors should be discontinued between 5 days and 2 weeks prior to CgA measurements. This is to allow CgA levels that might be spuriously elevated following PPI treatment to return to reference range.</p><p>An increased number of ECL cells possibly related to the increased serum gastrin levels, have been observed in both children and adults during long-term treatment with esomeprazole. The findings are considered to be of no clinical significance.</p><p>During long-term treatment with antisecretory drugs, gastric glandular cysts have been reported to occur at a somewhat increased frequency. These changes are a physiological consequence of pronounced inhibition of acid secretion, are benign and appear to be reversible.</p><p>Decreased gastric acidity due to any means including proton pump inhibitors, increases gastric counts of bacteria normally present in the gastrointestinal tract. Treatment with proton pump inhibitors may lead to slightly increased risk of gastrointestinal infections such</p><p>as Salmonella and Campylobacter and, in hospitalized patients, possibly also Clostridium difficile.</p><p>&nbsp;</p><p><strong>Clinical efficacy</strong></p><p>In two studies with ranitidine as an active comparator, Sesmo showed better effect in healing of gastric ulcers in patients using NSAIDs, including COX-2 selective NSAIDs.</p><p>In two studies with placebo as comparator, Sesmo showed better effect in the prevention of gastric and duodenal ulcers in patients using NSAIDs (aged &gt;60 and/or with previous ulcer), including COX-2 selective NSAIDs.</p><p>Paediatric population</p><p>In a study in paediatric GERD patients (&lt;1 to 17 years of age) receiving long-term PPI treatment, 61% of the children developed minor degrees of ECL cell hyperplasia with no known clinical significance and with no development of atrophic gastritis or carcinoid tumours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Drugs for acid-related disorders proton pump inhibitors ATC Code: A02BC05</p><p>Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. Both the R- and S-isomer of omeprazole have similar pharmacodynamics activity.</p><p>&nbsp;</p><p>Mechanism of action</p><p>Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+K+-ATPase &ndash; the acid pump and inhibits both basal and stimulated acid secretion.</p><p>Pharmacodynamic effects</p><p>After oral dosing with esomeprazole 20 mg and 40 mg the onset of effect occurs within one hour. After repeated administration with 20 mg esomeprazole once daily for five days, mean peak acid output after pentagastrin stimulation is decreased 90% when measured 6&ndash;7 hours after dosing on day five.</p><p>After five days of oral dosing with 20 mg and 40 mg of esomeprazole, intragastric pH above 4 was maintained for a mean time of 13 hours and 17 hours, respectively over 24 hours in symptomatic GERD patients. The proportion of patients maintaining an intragastric pH above 4 for at least 8, 12 and 16 hours respectively were for esomeprazole 20 mg 76%, 54% and 24%.</p><p>Corresponding proportions for esomeprazole 40 mg were 97%, 92% and 56%.</p><p>Using AUC as a surrogate parameter for plasma concentration, a relationship between inhibition of acid secretion and exposure has been shown.</p><p>Healing of reflux esophagitis with esomeprazole 40 mg occurs in approximately 78% of patients after four weeks, and in 93% after eight weeks.</p><p>One week&rsquo;s treatment with esomeprazole 20 mg b.i.d. and appropriate antibiotics, results in successful eradication of H. pylori in approximately 90% of patients.</p><p>After eradication treatment for one week, there is no need for subsequent monotherapy with antisecretory drugs for effective ulcer healing and symptom resolution in uncomplicated duodenal ulcers.</p><p>In a randomized, double blind, placebo-controlled clinical study, patients with endoscopically confirmed peptic ulcer bleeding characterized as Forrest Ia, Ib, IIa or IIb (9%, 43%, 38% and 10% respectively) were randomized to receive Sesmo solution for infusion (n=375) or placebo (n=389). Following endoscopic haemostasis, patients received either 80 mg esomeprazole as an intravenous infusion over 30 minutes followed by a continuous infusion of 8 mg per hour or placebo for 72 hours. After the initial 72-hour period, all patients received open label 40 mg oral Sesmo for 27 days for acid suppression. The occurrence of rebleeding within 3 days was 5.9% in the Sesmo treated group compared to 10.3% for the placebo group. At 30 days post- treatment, the occurrence of rebleeding in the Sesmo treated versus the placebo treated group was 7.7% vs 13.6%.</p><p>During treatment with antisecretory medicinal products, serum gastrin increases in response to the decreased acid secretion. Also CgA increases due to decreased gastric acidity. The increased CgA level may interfere with investigations for neuroendocrine tumours. Available published evidence suggests that proton pump inhibitors should be discontinued between 5 days and 2 weeks prior to CgA measurements. This is to allow CgA levels that might be spuriously elevated following PPI treatment to return to reference range.</p><p>An increased number of ECL cells possibly related to the increased serum gastrin levels, have been observed in both children and adults during long-term treatment with esomeprazole. The findings are considered to be of no clinical significance.</p><p>During long-term treatment with antisecretory drugs, gastric glandular cysts have been reported to occur at a somewhat increased frequency. These changes are a physiological consequence of pronounced inhibition of acid secretion, are benign and appear to be reversible.</p><p>&nbsp;</p><p>Decreased gastric acidity due to any means including proton pump inhibitors, increases gastric counts of bacteria normally present in the gastrointestinal tract. Treatment with proton pump inhibitors may lead to slightly increased risk of gastrointestinal infections such</p><p>as Salmonella and Campylobacter and, in hospitalized patients, possibly also Clostridium difficile.</p><p>&nbsp;</p><p><strong>Clinical efficacy</strong></p><p>In two studies with ranitidine as an active comparator, Sesmo showed better effect in healing of gastric ulcers in patients using NSAIDs, including COX-2 selective NSAIDs.</p><p>In two studies with placebo as comparator, Sesmo showed better effect in the prevention of gastric and duodenal ulcers in patients using NSAIDs (aged &gt;60 and/or with previous ulcer), including COX-2 selective NSAIDs.</p><p>Paediatric population</p><p>In a study in paediatric GERD patients (&lt;1 to 17 years of age) receiving long-term PPI treatment, 61% of the children developed minor degrees of ECL cell hyperplasia with no known clinical significance and with no development of atrophic gastritis or carcinoid tumours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction and development. Adverse reactions not observed in clinical studies, but seen in animals at exposure levels similar to clinical exposure levels and with possible relevance to clinical use were as follows:</p><p>Carcinogenicity studies in the rat with the racemic mixture have shown gastric ECL-cell hyperplasia and carcinoids. These gastric effects in the rat are the result of sustained, pronounced hypergastrinaemia secondary to reduced production of gastric acid and are observed after long- term treatment in the rat with inhibitors of gastric acid secretion.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hard gelatin capsule, Sugar Spheres, HydroxyPropyl Methylcellulose, Sodium Hydroxide, Titanium Dioxide, Talc, Methacrylic Acid Copolymer, Diethyl Phthalate, Polysorbate 80 (Tween 80).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30 &deg;C</p><p>Store in the original pack to protect from light &amp; moisture</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carton box contains: 28 Capsules, 4 strips (7 Capsules/Strip) &amp; 14 Capsules, 2 strips</p><p>(7 Capsules/Strip)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SAJA Pharmaceuticals Co. Ltd
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                June 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>